[Federal Register Volume 74, Number 109 (Tuesday, June 9, 2009)]
[Notices]
[Page 27350]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-13351]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on March 18, 2009, Norac Inc., 
405 S. Motor Avenue, P.O. Box 577, Azusa, California 91702-3232, made 
application by letter to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of Nabilone (7379), a basic class 
of controlled substance listed in schedule II.
    The company plans to manufacture bulk controlled substances for use 
in product development and for distribution to its customers.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such a substance, may file comments 
or objections to the issuance of the proposed registration pursuant to 
21 CFR 1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than August 10, 2009.

    Dated: June 3, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E9-13351 Filed 6-8-09; 8:45 am]
BILLING CODE 4410-09-P